What is Hyperspectral?
Hyperspectral is a pioneering technology firm that merges physics-based spectral data with sophisticated artificial intelligence to deliver rapid, reliable insights across critical sectors such as health care and food safety. Their proprietary platform, SpecAI, is engineered for real-time diagnostics, capable of identifying antibiotic-resistant infections and detecting food contamination risks, thereby bolstering public health and safety standards. Beyond these core applications, HyperSpectral's technology extends to quality control in manufacturing processes and environmental monitoring, ensuring product integrity and contributing to pollution reduction efforts. The company's vision is to empower a diverse range of industries, including defense, by translating complex scientific data into actionable intelligence.
How much funding has Hyperspectral raised?
Hyperspectral has raised a total of $34.3M across 3 funding rounds:
Multiple Rounds
$34.3M
Series A (2025): $15.5M with participation from Kibo, RRE Ventures, Correlation Ventures, and Avalanche Technology
Private Equity (2025): $6.7M, investors not publicly disclosed
Private Equity (2025): $12.1M, investors not publicly disclosed
Key Investors in Hyperspectral
Kibo
Kibo is a composable digital commerce platform provider, supporting B2C, D2C, and B2B organizations. They offer a modular platform for eCommerce, Order Management, and Subscriptions, aiming to simplify commerce operations and enhance customer experiences.
RRE Ventures
RRE Ventures is a venture capital firm focused on long-term partnerships with founders, investing in a diverse portfolio of startups. They aim to back exceptional teams and innovative ideas to foster growth and success.
Correlation Ventures
Correlation Ventures focuses on reinventing industries through innovative investment strategies and data science. They support companies in making rapid investment decisions to achieve lasting value, particularly those addressing significant challenges.
What's next for Hyperspectral?
With the recent major strategic investment and substantial enterprise-level funding, Hyperspectral is poised for accelerated growth and market expansion. The capital injection is expected to fuel further development of their SpecAI platform, enhance their diagnostic capabilities for infectious diseases and foodborne pathogens, and broaden their reach into new industrial and defense applications. This strategic financing will likely support scaling operations, expanding research and development initiatives, and solidifying their position as a leader in AI-driven spectral data analysis for critical safety and health applications.
See full Hyperspectral company page
